180 related articles for article (PubMed ID: 32864550)
1. Venous thromboembolism in primary central nervous system lymphoma during frontline chemoimmunotherapy.
Yuen HLA; Slocombe A; Heron V; Chunilal S; Shortt J; Tatarczuch M; Grigoriadis G; Patil S; Gregory GP; Opat S; Gilbertson M
Res Pract Thromb Haemost; 2020 Aug; 4(6):997-1003. PubMed ID: 32864550
[TBL] [Abstract][Full Text] [Related]
2. Incidence, risk factors and management of venous thromboembolism in patients with primary CNS lymphoma.
Saito M; Wages NA; Schiff D
J Neurooncol; 2021 Aug; 154(1):41-47. PubMed ID: 34164780
[TBL] [Abstract][Full Text] [Related]
3. Increased incidence of venous thromboembolism associated with inferior vena cava filter placement in patients diagnosed with isolated calf deep vein thrombosis after intracranial hemorrhage or intracranial operation.
Juan MCY; Patel P; Zerona N; Christie A; Fendrikova Mahlay N; McLennan G; Tefera L
J Thromb Thrombolysis; 2023 Feb; 55(2):297-303. PubMed ID: 36525155
[TBL] [Abstract][Full Text] [Related]
4. Incidence and characteristics of venous thromboembolism in Asian patients with primary central nervous system lymphoma undergoing chemotherapy.
Byun JM; Hong J; Yoon SS; Koh Y; Ock CY; Kim TM; Lee JH; Kim SH; Lee JO; Bang SM; Yhim HY; Bae SH; Mun YC; Oh D;
Thromb Res; 2019 Nov; 183():131-135. PubMed ID: 31677593
[TBL] [Abstract][Full Text] [Related]
5. High incidence of venous thromboembolism and major bleeding in patients with primary CNS lymphoma.
Mahajan A; Brunson A; Keegan THM; Rosenberg A; Wun T
Leuk Lymphoma; 2020 Nov; 61(11):2605-2613. PubMed ID: 32573292
[TBL] [Abstract][Full Text] [Related]
6. Venous Thromboembolism Prophylaxis with Low-Molecular-Weight Heparin in Primary Central Nervous System Lymphoma.
Gazal S; Lebel E; Kalish Y; Makranz C; Gatt ME; Goldschmidt N; Nachmias B
Oncol Res Treat; 2021; 44(1-2):52-57. PubMed ID: 33296909
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.
Amaral FC; Baptista-Silva JC; Nakano LC; Flumignan RL
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013683. PubMed ID: 36413425
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
9. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D; Debourdeau P; Beckers M; Baglin C; Bauersachs RM; Brenner B; Brilhante D; Falanga A; Gerotzafias GT; Haim N; Kakkar AK; Khorana AA; Lecumberri R; Mandala M; Marty M; Monreal M; Mousa SA; Noble S; Pabinger I; Prandoni P; Prins MH; Qari MH; Streiff MB; Syrigos K; Bounameaux H; Büller HR
J Thromb Haemost; 2013 Jan; 11(1):56-70. PubMed ID: 23217107
[TBL] [Abstract][Full Text] [Related]
10. Neuromuscular electrical stimulation for the prevention of venous thromboembolism.
Hajibandeh S; Hajibandeh S; Antoniou GA; Scurr JR; Torella F
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011764. PubMed ID: 29161465
[TBL] [Abstract][Full Text] [Related]
11. Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score.
Rupa-Matysek J; Gil L; Kaźmierczak M; Barańska M; Komarnicki M
Med Oncol; 2017 Dec; 35(1):5. PubMed ID: 29209847
[TBL] [Abstract][Full Text] [Related]
12. Decreased incidence of venous thromboembolism after spine surgery with early multimodal prophylaxis: Clinical article.
Cox JB; Weaver KJ; Neal DW; Jacob RP; Hoh DJ
J Neurosurg Spine; 2014 Oct; 21(4):677-84. PubMed ID: 25105337
[TBL] [Abstract][Full Text] [Related]
13. Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Hepatocellular Carcinoma.
Wang Y; Attar BM; Fuentes HE; Yu J; Zhang H; Tafur AJ
Clin Appl Thromb Hemost; 2018 Apr; 24(3):471-476. PubMed ID: 28288526
[TBL] [Abstract][Full Text] [Related]
14. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
[TBL] [Abstract][Full Text] [Related]
15. A Three-year Retrospective Study Looking at Preventing Hospital Acquired Thrombosis.
Kammath V; Gupta A; Bald A; Hope G; Kansal N; Al Samaraee A; Bhattacharya V
Cardiovasc Hematol Agents Med Chem; 2024 Jan; ():. PubMed ID: 38288832
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of venous thromboembolism and clinical application of inferior vena cava filter in China.
Zhang F; Gu J; Li HL;
J Vasc Surg Venous Lymphat Disord; 2023 Nov; 11(6):1149-1156. PubMed ID: 37196920
[TBL] [Abstract][Full Text] [Related]
17. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism.
Kakkos S; Kirkilesis G; Caprini JA; Geroulakos G; Nicolaides A; Stansby G; Reddy DJ
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD005258. PubMed ID: 35089599
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet agents for the treatment of deep venous thrombosis.
Flumignan CD; Nakano LC; Baptista-Silva JC; Flumignan RL
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012369. PubMed ID: 35876829
[TBL] [Abstract][Full Text] [Related]
19. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
